Document is current
Any future updates will be listed below
-
Authors
Ryu, Hyunho
Lee, So-Ryoung
Choi, Eue-Keun
Go, Young-Hae
Lee, Kyung-Yeon
Choi, JungMin
Han, Seokmoon
Kim, Jae-Hyun
Ahn, Hyo-Jeong
Kwon, Soonil
Kim, Bong-Seoung
Han, Kyung-Do
Oh, Seil
Lip, Gregory Y. H.
-
Funding
Funding for this research was provided by:
Patient-Centered Clinical Research Coordinating Center (PACEN), Ministry of Health & Welfare, Republic of Korea (RS-2021-KH119931)
National Research Foundation of Korea (RS-2024-00340590)
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 17 May 2025
First Online: 7 June 2025
Declarations
:
: This study was performed in accordance with the World Medical Association Declaration of Helsinki. The Institutional Review Board at the Seoul National University Hospital (E-2412-101-1597) authorized this study. Informed consent was waived since anonymous and deidentified information was used for analysis.
: These authors disclose the following: E-K.C. reports research grants or speaking fees from Abbott, Bayer, BMS/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd, Medtronic, Samjinpharm, Samsung Electronics Co., Ltd., Seers Technology, Skylabs, and Yuhan Corporation. G.Y.H.L. reports consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees are received personally. The remaining authors disclose no conflicts.
